Join our Newsletter
Browse by Category
-
Most Read This Week
- Vical Incorporated announces results of herpes vaccine trial
- NIH studying newly emerging Staphylococcus aureus strain
- University of Cincinnati researchers develop oral breast cancer vaccine
- Japan deals with rubella outbreak
- CDC issues update on fungal meningitis outbreak
- Swine-origin flu variant cases continue in U.S.
- Scientist map critical portion of anti-influenza antibody
- Boy dies from superbug infection at NIH hospital
- Progress made on new TB drug
Tags
Africa AIDS anthrax Avian flu Canada Cancer CDC Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola H1N1 H5N1 Hepatitis Hepatitis B HIV HPV Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Measles Medical Countermeasures meningitis MRSA Mumps News Pertussis pneumonia polio Preparedness research rotavirus Tuberculosis vaccine development West Nile virus whooping cough World Health Organization Yellow Fever
Tag Archives: pneumococcal disease
Pfizer demonstrates safety of Prevnar 13 for older children
TweetPfizer Inc., announced the results of a phase three study on Monday demonstrating that Prevnar 13(R) showed immunogenicity and established a safety profile in children ages five through 17. Prevnar 13(R) – Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) – … Read More »
Pfizer, Glaxo sign 10-year vaccine deal for poor
LONDON Read More »
Filed in News, Vaccine Development
Tagged immunization, meningitis, pneumococcal disease
Comments Off
Young kids should get new Prevnar, U.S. experts say
Children younger than 5 who already got four doses of Pfizer Inc.’s Prevnar 13 vaccine should get a fifth booster dose of the new version that covers more strains of pneumonia-causing bacteria. Read More »
Infection persists, despite vaccine, analysis finds
A vaccine introduced in 2000 has been highly effective in reducing the number of severe lung, blood and brain infections in infants and children. But at the same time, a serious and sometimes fatal complication has become more common. Read More »
PATH paying FDA for work on a pneumococcal disease vaccine
A nonprofit organization is paying the Food and Drug Administration to help develop a better vaccine against pneumococcal disease in poor countries, The New York Times reported Feb. 1. Read More »
Partnership to support vaccine formulation across PATH projects
PATH, an international nonprofit global health organization, recently signed an agreement with the University of Kansas Center for Research to support the advancement of vaccine candidates across its vaccine development portfolio. Read More »
Pneumonia shots not going to all who need them, authorities say
While a nationwide push for vaccination against H1N1 and seasonal flu has led to long lines for shots, another vaccine against a common and deadly flu complication Read More »